$ALKT

Alkami (ALKT) Q2 2026 Earnings Call Transcript

Alkami Technology (ALKT) reported Q2 2026 ARR of $511.7 million (+21% YoY) and total revenue of $129.8 million (+15.9% YoY). Non-GAAP gross margin was 63.0% and adjusted EBITDA was $19.4 million. Q3 revenue guidance is $132.7 million to $134.2 million; full-year 2026 revenue guidance is $528 million to $531 million. Bank clients under contract: 54.

Original reporting
Published Aug 8, 2026, 2:15 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 8, 2026, 2:39 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Alkami (ALKT) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$ALKTBullishHigh
01

Why it matters

Traders can update revenue and margin expectations using the provided Q3 revenue range and FY 2026 revenue and adjusted EBITDA guidance, plus operating cash flow improvement and repurchase activity.

02

Market read

The call provides fresh, decision-grade guidance ranges and KPI trajectory (ARR, RPU, RPO, churn, and margin expansion expectations) that can drive estimate revisions and near-term positioning.

03

What to watch

Database expense was deferred into 2027, so some cost pressure may reappear later; also, bank implementation speed and awareness gains may not translate linearly into future ARR conversion.

Relevance 9/10Novelty 9/10Timing: pre-market/next-session positioning after Q2 2026 earnings call and Q3/FY guidance

Background

This is Alkami Technology’s Q2 2026 earnings call transcript with detailed KPIs (ARR, RPU, registered users, RPO), profitability metrics, and explicit Q3 and full-year guidance.

Company-level read

Ticker impact

$ALKTBullishMedium confidence
Context

Alkami reported Q2 2026 ARR of $511.7M (+21% YoY) and guided Q3 revenue to $132.7M-$134.2M, plus FY 2026 EBITDA of $96M-$98M.

Expected impact

Likely positive bias for the next trading session and into earnings revisions, assuming the market rewards the raised/confirmed growth and margin trajectory.

Evidence & confidence

The article contains a full earnings call transcript with specific quarterly and full-year guidance, margin and cash-flow improvements, and capital return (repurchases), which are direct inputs to near-term estimates and sentiment.

Market effects

Reinforces demand for digital banking software platforms and bank-market penetration as a growth driver for fintech infrastructure vendors.

No explicit regional macro linkage beyond US bank adoption commentary.

Limited, as the disclosed metrics focus on community financial institutions and bank clients rather than global expansion.

Counterpoint

Non-GAAP gross margin fell to 63.0% from 65.1% due to lower termination fee revenue, which could signal mix volatility despite ARR growth.

Key entities

  • Alkami Technology, Inc.

    Subject of the earnings call, reporting Q2 2026 results and issuing Q3 and full-year 2026 guidance.

  • Alex Shootman

    CEO who discussed bank-market scaling, product adoption, and AI-integrated product growth.

  • Cassandra Hudson

    CFO who highlighted margin drivers, termination fee variability, and cash-flow improvement.

Related articles

$ALKTMed

Alkami (ALKT)’s Strategic Review Is Over. What Could Drive the Stock Next?

Alkami Technology (ALKT) decided to remain independent, causing a 20% stock drop. JPMorgan downgraded it to Underweight. The company reports strong recurring revenue growth, expanding margins, and bank expansion. Needham raised its price target to $25. JPMorgan argues ALKT should be valued against Q2 Holdings, warranting a discount. Hedge funds show mixed signals. The focus is now on execution and growth.

$ALKTHigh

Why is Alkami Technology stock plunging today?

Alkami Technology (ALKT) shares fell 18.7% to $14.71 in pre-market trading after its sale process failed to secure a deal, erasing the M&A premium. Activist investor Jana Partners criticized the process, and analysts have cut price targets. The stock is near its 52-week low, with no near-term catalysts. Broader market weakness also contributed to the decline.

$ALKTMed

Alkami Announces Second Quarter 2026 Financial Results

ALKAMI TECHNOLOGY, INC. (ALKT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Alkami Announces Second Quarter 2026 Financial Results PLANO, Texas, July 29, 2026 (PRNewswire) -- Alkami Technology, Inc. (Nasdaq: ALKT) (“Alkami” or “the Company”), a digital sales and service platform provider for financial institutions in the U.S., today announce